10 Sci-Fi Weapons That Actually Exist

Sure, the gear may look like it came straight out of Avatar or Battlestar Galactica. But all of the laser weapons, robots, sonic blasters and puke rays pictured here are real. Some of these weapons have already found their way onto the battlefield. If the rest of this sci-fi arsenal follows, war may soon be unrecognizable.

Read on for a look at some of these futuristic weapons being tested today.

Above:

The XM-25 grenade launcher is equipped with a laser rangefinder and on-board computer. It packs a magazine of four 25mm projectiles, and programs them to detonate as they pass by their targets. That feature will allow soldiers to strike enemies who are taking cover. By 2012, the Army hopes to arm every infantry squad and Special Forces unit with at least one of the big guns.

In August, a lucky soldier got to pull the trigger, and fire off a HEAB, or High Explosive Air Burst, round at the Aberdeen Testing Ground in Maryland. Those projectiles pack quite a punch. They are purportedly 300 percent more effective than normal ammo, and will be able to strike targets as far as 700 meters (2,300 feet) away.

Photo courtesy U.S. Army

Pages: 1 2 3 4 5 6 7 8 9 10 View All

Read More..

Final “Twilight” dawns with $30 million from late-night shows

LOS ANGELES (Reuters) – Bella and Edward’s big-screen farewell lit up box offices with $ 30.4 million in late-night ticket sales for the finale of the blockbuster “Twilight” vampire series, production studio Summit Entertainment said on Friday.

The U.S. and Canadian box office receipts for “The Twilight Saga: Breaking Dawn, Part 2″ beat initial sales for each of the previous four films in the franchise, though the final installment got a boost from late Thursday night previews.

Last year’s “Breaking Dawn, Part 1″ kicked off with $ 30.3 million from shows just after midnight on the Friday that it debuted, according to figures from Hollywood.com. Summit, a unit of Lions Gate Entertainment Corp, did not provide Friday-only numbers for “Breaking Dawn, Part 2.”

The record for opening-night sales belongs to “Harry Potter and the Deathly Hallows, Part 2,” the finale in the boy-wizard series that grabbed $ 43.5 million when it debuted in July 2011.

Box office watchers say the “Twilight” finale has a shot at setting the franchise record for opening weekend sales when receipts through Sunday are tallied. “The Twilight Saga: New Moon,” released in November 2009, now ranks as the biggest opening in the series, with $ 142.8 million in sales over the first three days after its release in November 2009.

“Breaking Dawn – Part 2″ stars Kristen Stewart, Robert Pattinson and Taylor Lautner in the conclusion of angst-ridden vampire and werewolf love triangle created by author Stephenie Meyer in a series of young adult books. In the final film, wedded vampires Bella and Edward must protect their daughter from an ancient vampire clan.

Opening weekend will get a lift from fans who rush out to see the movie because it is the last film in the popular series, said Paul Dergarabedian, president of the box office division of Hollywood.com. He projects domestic three-day sales will reach $ 145 million to $ 150 million.

“Like ‘Potter,’ the final installment of this will benefit from the cachet of being the last one,” he said.

(Reporting By Lisa Richwine; editing by Andrew Hay)

Movies News Headlines – Yahoo! News

Read More..

Drug Shortages Are Becoming Persistent in U.S.

Paul Davis, the chief of a rural ambulance squad in southern Ohio, was down to his last vial of morphine earlier this fall when a woman with a broken leg needed a ride to the hospital.

The trip was 30 minutes, and the patient was in pain. But because of a nationwide shortage, his morphine supply had dwindled from four doses to just one, presenting Mr. Davis with a stark quandary. Should he treat the woman, who was clearly suffering? Or should he save it for a patient who might need it more?

In the end, he opted not to give her the morphine, a decision that haunts him still. “I just feel like I’m not doing my job,” said Mr. Davis, who is chief of the rescue squad in Vernon, Ohio. He has since refilled his supply. “I shouldn’t have to make those kinds of decisions.”

From rural ambulance squads to prestigious hospitals, health care workers are struggling to keep vital medicines in stock because of a drug shortage crisis that is proving to be stubbornly difficult to fix. Rationing is just one example of the extraordinary lengths being taken to address the shortage, which health care workers say has ceased to be a temporary emergency and is now a fact of life. In desperation, they are resorting to treating patients with less effective alternative medicines and using expired drugs. The Cleveland Clinic has hired a pharmacist whose only job is to track down hard-to-find drugs.

Caused largely by an array of manufacturing problems, the shortage has prompted Congressional hearings, a presidential order and pledges by generic drug makers to communicate better with federal regulators.

The problem peaked in 2011, when a record 251 drugs were declared in short supply. This year, slightly more than 100 were placed on the list, and workers say the battle to keep pharmacy shelves stocked continues unabated. The list of hard-to-find medicines ranges from basic drugs like the heart medicine nitroglycerin to a lidocaine injection, which is used to numb tissue before surgery.

A deadly meningitis outbreak caused by contamination at a large drug producer could worsen the situation, federal officials have warned. The Food and Drug Administration said that shortages of six drugs — medicines used during surgery and to treat conditions like congestive heart failure — could get worse after a big compounding pharmacy closed over concerns about drug safety. The pharmacy, Ameridose, shares some management with the New England Compounding Center, which is at the center of a meningitis outbreak that has claimed 33 lives.

“When you can’t treat basic things — cardiac arrest, pain management, seizures — you’re in trouble,” said Dr. Carol Cunningham, the state medical director for the Ohio Department of Public Safety’s emergency services division. “When you only have five tools in your toolbox and three of them are gone, what do you do?”

Dr. Margaret A. Hamburg, the F.D.A. commissioner, said in an interview this week that she was “guardedly optimistic” that the shortage crisis was abating. “I think there’s been an enormous amount of progress,” she said. “We’re seeing real change in the number of shortages that we’re able to recognize early.” More than 150 new shortages have been prevented this year, according to the agency.

But Erin Fox, who tracks supply levels for a broader range of drugs at the University of Utah, said once a drug became scarce, it tended to stay scarce. The university’s Drug Information Service was actively tracking 282 hard-to-find products by the end of the third quarter of this year, a record.

“The shortages we have aren’t going away — they’re not resolving,” she said. “But the good news is we’re not piling more shortages on top.”

In 2011, prompted by emotional pleas by cancer patients and others who said the drug shortage was threatening lives, President Obama issued an executive order requiring drug makers to notify the F.D.A. when a shortage appeared imminent. The agency also loosened some restrictions on importing drugs, and sped up approvals by other manufacturers to make certain medicines.

A law passed this summer contains several provisions aimed at improving the situation, including expediting approval of new generic medicines and requiring the agency’s enforcement unit to better coordinate with its drug-shortage officials before it takes action against a manufacturer.

Ralph G. Neas, the chief executive of the Generic Pharmaceutical Association, said fixing the drug shortage was complex and would take time, but was a top priority. “One shortage is one shortage too many,” he said. “One patient not getting a critical drug is one patient too many.”

Federal drug officials trace much of the drug shortage crisis to delays at plants that make sterile injectable drugs, which account for about 80 percent of the scarce medicines. Nearly a third of the industry’s manufacturing capacity is not running because of plant closings or shutdowns to fix serious quality issues. Other shortages have been caused by supply disruptions of the raw ingredients used to make the drugs, or by manufacturers exiting the market.

Read More..

Drug Shortages Are Becoming Persistent in U.S.

Paul Davis, the chief of a rural ambulance squad in southern Ohio, was down to his last vial of morphine earlier this fall when a woman with a broken leg needed a ride to the hospital.

The trip was 30 minutes, and the patient was in pain. But because of a nationwide shortage, his morphine supply had dwindled from four doses to just one, presenting Mr. Davis with a stark quandary. Should he treat the woman, who was clearly suffering? Or should he save it for a patient who might need it more?

In the end, he opted not to give her the morphine, a decision that haunts him still. “I just feel like I’m not doing my job,” said Mr. Davis, who is chief of the rescue squad in Vernon, Ohio. He has since refilled his supply. “I shouldn’t have to make those kinds of decisions.”

From rural ambulance squads to prestigious hospitals, health care workers are struggling to keep vital medicines in stock because of a drug shortage crisis that is proving to be stubbornly difficult to fix. Rationing is just one example of the extraordinary lengths being taken to address the shortage, which health care workers say has ceased to be a temporary emergency and is now a fact of life. In desperation, they are resorting to treating patients with less effective alternative medicines and using expired drugs. The Cleveland Clinic has hired a pharmacist whose only job is to track down hard-to-find drugs.

Caused largely by an array of manufacturing problems, the shortage has prompted Congressional hearings, a presidential order and pledges by generic drug makers to communicate better with federal regulators.

The problem peaked in 2011, when a record 251 drugs were declared in short supply. This year, slightly more than 100 were placed on the list, and workers say the battle to keep pharmacy shelves stocked continues unabated. The list of hard-to-find medicines ranges from basic drugs like the heart medicine nitroglycerin to a lidocaine injection, which is used to numb tissue before surgery.

A deadly meningitis outbreak caused by contamination at a large drug producer could worsen the situation, federal officials have warned. The Food and Drug Administration said that shortages of six drugs — medicines used during surgery and to treat conditions like congestive heart failure — could get worse after a big compounding pharmacy closed over concerns about drug safety. The pharmacy, Ameridose, shares some management with the New England Compounding Center, which is at the center of a meningitis outbreak that has claimed 33 lives.

“When you can’t treat basic things — cardiac arrest, pain management, seizures — you’re in trouble,” said Dr. Carol Cunningham, the state medical director for the Ohio Department of Public Safety’s emergency services division. “When you only have five tools in your toolbox and three of them are gone, what do you do?”

Dr. Margaret A. Hamburg, the F.D.A. commissioner, said in an interview this week that she was “guardedly optimistic” that the shortage crisis was abating. “I think there’s been an enormous amount of progress,” she said. “We’re seeing real change in the number of shortages that we’re able to recognize early.” More than 150 new shortages have been prevented this year, according to the agency.

But Erin Fox, who tracks supply levels for a broader range of drugs at the University of Utah, said once a drug became scarce, it tended to stay scarce. The university’s Drug Information Service was actively tracking 282 hard-to-find products by the end of the third quarter of this year, a record.

“The shortages we have aren’t going away — they’re not resolving,” she said. “But the good news is we’re not piling more shortages on top.”

In 2011, prompted by emotional pleas by cancer patients and others who said the drug shortage was threatening lives, President Obama issued an executive order requiring drug makers to notify the F.D.A. when a shortage appeared imminent. The agency also loosened some restrictions on importing drugs, and sped up approvals by other manufacturers to make certain medicines.

A law passed this summer contains several provisions aimed at improving the situation, including expediting approval of new generic medicines and requiring the agency’s enforcement unit to better coordinate with its drug-shortage officials before it takes action against a manufacturer.

Ralph G. Neas, the chief executive of the Generic Pharmaceutical Association, said fixing the drug shortage was complex and would take time, but was a top priority. “One shortage is one shortage too many,” he said. “One patient not getting a critical drug is one patient too many.”

Federal drug officials trace much of the drug shortage crisis to delays at plants that make sterile injectable drugs, which account for about 80 percent of the scarce medicines. Nearly a third of the industry’s manufacturing capacity is not running because of plant closings or shutdowns to fix serious quality issues. Other shortages have been caused by supply disruptions of the raw ingredients used to make the drugs, or by manufacturers exiting the market.

Read More..

FHA projected to exhaust reserves, could need bailout

WASHINGTON -- The Federal Housing Administration, which has played a crucial role in stabilizing the housing market, said it ended September with $16.3 billion in projected losses -- a possible prelude to a taxpayer bailout.

The precarious financial situation could force the FHA, which has been self-funded through mortgage insurance premiums since it was created during the Great Depression, to tap the U.S. Treasury to stay afloat.

The agency said a determination on whether it needs a bailout won't come until next year.

The FHA is required to maintain enough cash reserves to cover losses on the mortgages it insures. But in its annual actuarial report to Congress, the agency said a slower-than-anticipated housing market recovery has led its reserves to fall $16.3 billion below anticipated losses.

The FHA's cash reserves aren't supposed to drop below 2% of projected losses. They ended the 2012 fiscal year at -1.44%, down from the seriously low level of 0.24% at the end of 2011.

Quiz: How much do you know about the 'fiscal cliff'?

The FHA and the Department of Housing and Urban Development, which oversees it, said the report "does not mean FHA has insufficient cash to pay insurance claims, a current operating deficit or will need to immediately draw funds from the Treasury."

A request for taxpayer money would come in President Obama's 2014 budget, set to be released in February, with a final determination of whether the FHA needs the funds coming next September. The FHA has permanent and indefinite authority to draw money from the Treasury, although it has never had to use that power.

The FHA does not lend money, but guarantees loans made by banks in exchange for insurance premiums. The agency's role has expanded since the crash of the subprime mortgage market, and it now insures about $1.1 trillion in loans, according to Inside Mortgage Finance.

But the expanded role, including backing mortgages with as little as 3.5% down payment and for some people who have undergone recent foreclosures, has taken a toll on its finances. The agency boosted premiums and took other steps in 2009 to shore up its capital reserves.

"While the loans made during this administration remain the strongest in the agency's history, we take the findings of the independent actuary very seriously," said acting FHA Commissioner Carol Galante. "We will continue to take aggressive steps to protect FHA's financial health while ensuring that FHA continues to perform its historic role of providing access to homeownership for underserved communities and supporting the housing market during tough economic times."

[For the Record, 5:13 a.m. Nov. 16: A previous version of this post referred to the FHA as the Federal Housing Agency. It is the Federal Housing Administration.]

ALSO:

Obama slashes fees on FHA-backed mortgages

FHA could need taxpayer bailout next year, report says

FHA gives those who defaulted on homes another chance

Follow Jim Puzzanghera on Twitter and Google+.

Read More..

Russia's Stealth Fighter Could Match U.S. Jets, Analyst Says

Russia’s T-50 stealth fighter prototype, the first radar-evading warplane outside the U.S. when it debuted in January 2010, is slightly less stealthy than the American F-22 and about equal to the smaller F-35. But in several other respects the new warplane from the Russian Sukhoi design bureau is actually superior to the American models.

That’s the surprising conclusion of the first-ever public scientific analysis of the T-50′s Radar Cross-Section (RCS), completed this week by Dr. Carlo Kopp, an analyst with the independent think tank Air Power Australia.

“The shaping of the T-50 is inferior to that of the F-22 Raptor,” Kopp writes in his dense, jargon-heavy report. But the F-35 and T-50, he adds, exhibit “similar … RCS behavior.”

But Kopp’s assessment of the T-50 comes with caveats. Quite a few of them, actually. To match the stealthiness of the Lockheed Martin F-35 — to say nothing of the company’s F-22 — Sukhoi’s engineers will have to, among other changes, modify the T-50′s engines to a less obtrusive fitting and add a layer of radar-absorbing material to the plane’s skin.

With the revised engines and skin, the T-50′s “specular RCS performance will satisfy the Very Low Observable (VLO) requirement that strong specular returns are absent in the nose sector angular domain,” Kopp writes. Translated into plain English, Kopp’s saying that an optimized version of the Russian jet could be very, very difficult to detect by most radars as it’s bearing down on them.

Major refinements are standard practice as stealth prototypes go through development, it’s worth noting. The F-22 and the F-35 underwent big design changes as each was developed over 15 years or more. The T-50, only four of which have been built, has been flying for just under three years and isn’t scheduled to enter frontline service until 2016 at the earliest. There’s time for the Russians to finesse the design, just as the Chinese are doing with their stealth planes.

Granted, by 2016 the Americans could possess hundreds of combat-ready F-35s plus the roughly 180 F-22s already in service. The T-50 could make up for its lateness with impressive performance that in some ways exceeds even the F-22′s vaunted capabilities.

One Russian advantage is what Kopp calls “extreme plus agility” — a consequence of the T-50′s “advanced aerodynamic design, exceptional thrust/weight ratio performance and three dimensional thrust vectoring integrated with an advanced digital flight control system.”

The second advantage: “exceptional combat persistence, the result of an unusually large 25,000-pound internal fuel load,” Kopp writes. The T-50 could keep flying and fighting long after the F-22 and F-35 have run out of gas.

Moreover, the T-50 will dodge certain radars better than others, according to Kopp — and U.S. sensors are among the worst at detecting the T-50′s unique shape, he contends. Kopp’s breakdown of T-50 RCS by radar type shows Chinese “counter-VLO radars,” specifically designed to spot American stealth planes, detecting the T-50 best.

The next best sensors to use against the Russian fighter is the UHF radar aboard the U.S. Navy’s E-2 early-warning planes. American fighter radars, including those aboard the F-22 and F-35, are of middling effectiveness against the T-50, Kopp asserts.

“No fundamental obstacles exist in the shaping design of the T-50 prototype which might preclude its development into a genuine Very Low Observable design,” Kopp concludes.

In other words: Watch out, America! You’re now only one of three countries with a truly radar-evading warplane in the air.

Read More..

Juanes, Jesse & Joy take home top Latin Grammys

LAS VEGAS (Reuters) – Colombian rocker Juanes and the Mexican brother and sister pop duo Jesse & Joy took home the top Latin Grammys on Thursday in Las Vegas on a night in which the contemporary triumphed over the traditional.

Juanes, one of the most well known Latin American stars worldwide, won the coveted album of the year with his “MTV Unplugged,” which also won best long-form video. Dominican singer and songwriter Juan Luis Guerra won producer of the year for Juanes‘ album.

“Here’s to the maestro Juan Luis Guerra for making this possible,” said Juanes, 40, who now has won 19 Latin Grammys, tying him with reggaeton group Calle 13 for the most awards.

Guerra, who made the romantic Bachata music famous and is known to sweep the awards from the Latin Academy of Recording Arts and Sciences, led the nominations with six nods this year. But he lost out on the big awards for record and song of the year with his “En El Cielo No Hay Hospital” (In Heaven There Is No Hospital).

Those two awards went to “Corre!” (Run!) by Jesse & Joy, the duo from Mexico City who won best new artists in the same Las Vegas venue in 2007. Their third studio album Con Quien Se Queda El Perro? (Who Is The Dog Staying With?) lost out on album of the year, but won best contemporary pop vocal album.

“Viva Mexico!,” said Jesse upon accepting record of the year, a phrase repeated several times by winners at the 13th edition of the Latin Grammys Thursday night.

Like Jesse & Joy five years earlier, Mexican pop group 3BallMTY won best new artists with their musical style known as “tribal guarachero,” a mix of Mexican cumbia and electronic dance music.

The trio, barely beyond their teenage years, found success on both sides of the U.S.-Mexico border with their debut album “Intentalo” (Try It). They dedicated their Latin Grammy to Mexican DJs.

Mexico’s Carla Morrison won best alternative music album with “Dejenme Llorar” (Let Me Cry). Wearing a red dress and sporting multiple tattoos on her arms, she let loose an expletive on the live broadcast after crying out “Viva Mexico!”

Among the top performances of the night were Juanes playing with veteran guitarrist Carlos Santana. The show opened with Miami-born rapper Pitbull, who sings in both English and Spanish.

Brazilian singer and songwriter Caetano Veloso was honored as the Latin Recording Academy‘s person of the year in a ceremony on Wednesday. A founder of the 1960s musical movement known as Tropicalia, Veloso continues to to be one of Brazil’s most popular and innovative artists at 70 years of age.

(Writing by Mary Milliken; Editing by Lisa Shumaker)

Music News Headlines – Yahoo! News

Read More..

For Alzheimer’s, Detection Advances Outpace Treatment Options

Joshua Lott for The New York Times

Awilda Jimenez got a scan for Alzheimer’s after she started forgetting things. It was positive.

When Awilda Jimenez started forgetting things last year, her husband, Edwin, felt a shiver of dread. Her mother had developed Alzheimer’s in her 50s. Could his wife, 61, have it, too?

He learned there was a new brain scan to diagnose the disease and nervously agreed to get her one, secretly hoping it would lay his fears to rest. In June, his wife became what her doctor says is the first private patient in Arizona to have the test.

“The scan was floridly positive,” said her doctor, Adam S. Fleisher, director of brain imaging at the Banner Alzheimer’s Institute in Phoenix.

The Jimenezes have struggled ever since to deal with this devastating news. They are confronting a problem of the new era of Alzheimer’s research: The ability to detect the disease has leapt far ahead of treatments. There are none that can stop or even significantly slow the inexorable progression to dementia and death.

Families like the Jimenezes, with no good options, can only ask: Should they live their lives differently, get their affairs in order, join a clinical trial of an experimental drug?

“I was hoping the scan would be negative,” Mr. Jimenez said. “When I found out it was positive, my heart sank.”

The new brain scan technology, which went on the market in June, is spreading fast. There are already more than 300 hospitals and imaging centers, located in most major metropolitan areas, that are ready to perform the scans, according to Eli Lilly, which sells the tracer used to mark plaque for the scan.

The scans show plaques in the brain — barnaclelike clumps of protein, beta amyloid — that, together with dementia, are the defining feature of Alzheimer’s disease. Those who have dementia but do not have excessive plaques do not have Alzheimer’s. It is no longer necessary to wait until the person dies and has an autopsy to learn if the brain was studded with plaques.

Many insurers, including Medicare, will not yet pay for the new scans, which cost several thousand dollars. And getting one comes with serious risks. While federal law prevents insurers and employers from discriminating based on genetic tests, it does not apply to scans. People with brain plaques can be denied long-term care insurance.

The Food and Drug Administration, worried about interpretations of the scans, has required something new: Doctors must take a test showing they can read them accurately before they begin doing them. So far, 700 doctors have qualified, according to Eli Lilly. Other kinds of diagnostic scans have no such requirement.

In another unusual feature, the F.D.A. requires that radiologists not be told anything about the patient. They are generally trained to incorporate clinical information into their interpretation of other types of scans, said Dr. R. Dwaine Rieves, director of the drug agency’s Division of Medical Imaging Products.

But in this case, clinical information may lead radiologists to inadvertently shade their reports to coincide with what doctors suspect is the underlying disease. With Alzheimer’s, Dr. Rieves said, “clinical impressions have been misleading.”

“This is a big change in the world of image interpretation,” he said.

Like some other Alzheimer’s experts, Dr. Fleisher used the amyloid scan for several years as part of a research study that led to its F.D.A. approval. Subjects were not told what the scans showed. Now, with the scan on the market, the rules have changed.

Dr. Fleisher’s first patient was Mrs. Jimenez. Her husband, the family breadwinner, had lost his job as a computer consultant when the couple moved from New York to Arizona to take care of Mrs. Jimenez’s mother. Paying several thousand dollars for a scan was out of the question. But Dr. Fleisher found a radiologist, Dr. Mantej Singh Sra of Sun Radiology, who was so eager to get into the business that he agreed to do Mrs. Jimenez’s scan free. His plan was to be the first in Arizona to do a scan, and advertise it.

After Dr. Sra did the scan, the Jimenezes returned to Dr. Fleisher to learn the result.

Dr. Fleisher, sad to see so much plaque in Mrs. Jimenez’s brain, referred her to a psychiatrist to help with anxiety and suggested she enter clinical trials of experimental drugs.

But Mr. Jimenez did not like that idea. He worried about unexpected side effects.

“Tempting as it is, where do you draw the line?” he asks. “At what point do you take a risk with a loved one?”

At Mount Sinai Medical Center in New York, Dr. Samuel E. Gandy found that his patients — mostly affluent — were unfazed by the medical center’s $3,750 price for the scan. He has been ordering at least one a week for people with symptoms ambiguous enough to suggest the possibility of brain plaques.

Most of his patients want their names kept confidential, fearing an inability to get long-term care insurance, or just wanting privacy.

Read More..

Israel attack on Gaza: Familiar tension, new circumstances

JERUSALEM — Israel's surprise air assault on Gaza Strip militants killed the top military commander of Hamas and set the rivals on a familiar course that could end with another major confrontation — but in unpredictable new circumstances created by the "Arab Spring."

Compared with its past campaigns against Hamas, Israel is likely to find itself more restrained politically and militarily in the new landscape.

Rather than being able to count on former Egyptian President Hosni Mubarak to help isolate Hamas, as he did during a 22-day operation four years ago, Israel must weigh whether another large-scale Gaza offensive would endanger the landmark 1979 peace accord with Egypt, which has long served as a cornerstone of regional stability.

By Wednesday evening, Egypt's new Islamist president, Mohamed Morsi, announced he was recalling the country's ambassador to Israel to protest the assault on the Palestinian territory.

"It's a completely new game for Israel," said Yoram Meital, an Egypt expert at the Herzog Center for Middle East Studies and Diplomacy at Ben-Gurion University. "The equation before was between Israel and the Palestinians. Now it's a triangle, involving Egypt too."

Israel's offensive four years ago killed 1,200 Palestinians, but Mubarak brushed aside his own people's support for besieged Gazans and helped Israel seal Gaza's border.

The course of Israel's military campaign could be shaped by Morsi's decisions, analysts say.

Unlike his deposed predecessor, Morsi will find it difficult to ignore the anti-Israel mood of the Egyptian street. Israel is worried Egypt might open the Rafah border crossing to humanitarian aid or even Islamic fighters to help Gazans, Meital said.

"Israel is taking a very bold risk here because if this campaign continues, it could be gambling with the relationship with Egypt," he said.

Both Hamas, which has been emboldened by the new Egyptian government, and Israel, which has clashed repeatedly with it, will be watching closely to see whether Morsi comes out more strongly against Israel in the coming days or adopts a more pragmatic approach, perhaps trying to broker a cease-fire.

Besides public sentiment, Morsi must take into account his relationship with the United States and other world powers. He is seeking billions of dollars in aid and investment from the West to help the Egyptian economy. Some analysts say that even though Morsi will have to respond to be a credible Arab leader, Egyptians are more concerned with domestic problems.

Egyptian tribal leaders have blamed Hamas and other Palestinian groups for aiding the resurgence of deadly militant networks in the Sinai peninsula, who have attacked Egyptian government forces there.

Although he recalled his ambassador, Morsi did not immediately comment in public. But other leaders in the Muslim Brotherhood organization said the country would not tolerate another Israeli campaign in Gaza.

"The brutal aggression on Gaza proves that Israel has not yet learned that Egypt has changed," said Saad Katatni, head of the Muslim Brotherhood's Freedom and Justice Party.

Israeli military officials said the assault could last several days. The campaign is aimed at "defending the people of Israel who have been under rocket attack and crippling terrorist organizations' capabilities," said Israel Defense Forces spokeswoman Lt. Col. Avital Leibovitz.

Tension between Israel and Gaza militants has been mounting for nearly a week, following a missile attack against an Israeli jeep along the Gaza border that left four soldiers wounded.

In the ensuring back-and-forth violence, Hamas and other militant groups fired more than 120 rockets and mortar rounds into southern Israel, injuring several Israeli civilians and damaging property.

Israeli Prime Minister Benjamin Netanyahu has faced growing pressure to move aggressively to stop the attacks, which have terrified nearly 1 million southern Israelis and crippled daily activities.

Over the last year, Hamas, an offshoot of the Muslim Brotherhood, has resumed a more hostile stance toward Israel, betting that Morsi's election would strengthen its hand.

After observing a self-imposed cease-fire for most of the last four years, militants in recent months increased their attacks on Israel, using new types of weaponry acquired in Libya last year after the chaotic fall of Moammar Kadafi, such as antitank and antiaircraft missiles.

Read More..

Kill the Password: Why a String of Characters Can't Protect Us Anymore

You have a secret that can ruin your life.

It’s not a well-kept secret, either. Just a simple string of characters—maybe six of them if you’re careless, 16 if you’re cautious—that can reveal everything about you.

Your email. Your bank account. Your address and credit card number. Photos of your kids or, worse, of yourself, naked. The precise location where you’re sitting right now as you read these words. Since the dawn of the information age, we’ve bought into the idea that a password, so long as it’s elaborate enough, is an adequate means of protecting all this precious data. But in 2012 that’s a fallacy, a fantasy, an outdated sales pitch. And anyone who still mouths it is a sucker—or someone who takes you for one.

No matter how complex, no matter how unique, your passwords can no longer protect you.

Look around. Leaks and dumps—hackers breaking into computer systems and releasing lists of usernames and passwords on the open web—are now regular occurrences. The way we daisy-chain accounts, with our email address doubling as a universal username, creates a single point of failure that can be exploited with devastating results. Thanks to an explosion of personal information being stored in the cloud, tricking customer service agents into resetting passwords has never been easier. All a hacker has to do is use personal information that’s publicly available on one service to gain entry into another.

This summer, hackers destroyed my entire digital life in the span of an hour. My Apple, Twitter, and Gmail passwords were all robust—seven, 10, and 19 characters, respectively, all alphanumeric, some with symbols thrown in as well—but the three accounts were linked, so once the hackers had conned their way into one, they had them all. They really just wanted my Twitter handle: @mat. As a three-letter username, it’s considered prestigious. And to delay me from getting it back, they used my Apple account to wipe every one of my devices, my iPhone and iPad and MacBook, deleting all my messages and documents and every picture I’d ever taken of my 18-month-old daughter.

The age of the password is over. We just haven’t realized it yet.

Since that awful day, I’ve devoted myself to researching the world of online security. And what I have found is utterly terrifying. Our digital lives are simply too easy to crack. Imagine that I want to get into your email. Let’s say you’re on AOL. All I need to do is go to the website and supply your name plus maybe the city you were born in, info that’s easy to find in the age of Google. With that, AOL gives me a password reset, and I can log in as you.

First thing I do? Search for the word “bank” to figure out where you do your online banking. I go there and click on the Forgot Password? link. I get the password reset and log in to your account, which I control. Now I own your checking account as well as your email.

This summer I learned how to get into, well, everything. With two minutes and $4 to spend at a sketchy foreign website, I could report back with your credit card, phone, and Social Security numbers and your home address. Allow me five minutes more and I could be inside your accounts for, say, Amazon, Best Buy, Hulu, Microsoft, and Netflix. With yet 10 more, I could take over your AT&T, Comcast, and Verizon. Give me 20—total—and I own your PayPal. Some of those security holes are plugged now. But not all, and new ones are discovered every day.

The common weakness in these hacks is the password. It’s an artifact from a time when our computers were not hyper-connected. Today, nothing you do, no precaution you take, no long or random string of characters can stop a truly dedicated and devious individual from cracking your account. The age of the password has come to an end; we just haven’t realized it yet.

Passwords are as old as civilization. And for as long as they’ve existed, people have been breaking them.

In 413 BC, at the height of the Peloponnesian War, the Athenian general Demosthenes landed in Sicily with 5,000 soldiers to assist in the attack on Syracusae. Things were looking good for the Greeks. Syracusae, a key ally of Sparta, seemed sure to fall.

But during a chaotic nighttime battle at Epipole, Demosthenes’ forces were scattered, and while attempting to regroup they began calling out their watchword, a prearranged term that would identify soldiers as friendly. The Syracusans picked up on the code and passed it quietly through their ranks. At times when the Greeks looked too formidable, the watchword allowed their opponents to pose as allies. Employing this ruse, the undermatched Syracusans decimated the invaders, and when the sun rose, their cavalry mopped up the rest. It was a turning point in the war.

The first computers to use passwords were likely those in MIT’s Compatible Time-Sharing System, developed in 1961. To limit the time any one user could spend on the system, CTSS used a login to ration access. It only took until 1962 when a PhD student named Allan Scherr, wanting more than his four-hour allotment, defeated the login with a simple hack: He located the file containing the passwords and printed out all of them. After that, he got as much time as he wanted.

During the formative years of the web, as we all went online, passwords worked pretty well. This was due largely to how little data they actually needed to protect. Our passwords were limited to a handful of applications: an ISP for email and maybe an ecommerce site or two. Because almost no personal information was in the cloud—the cloud was barely a wisp at that point—there was little payoff for breaking into an individual’s accounts; the serious hackers were still going after big corporate systems.

So we were lulled into complacency. Email addresses morphed into a sort of universal login, serving as our username just about everywhere. This practice persisted even as the number of accounts—the number of failure points—grew exponentially. Web-based email was the gateway to a new slate of cloud apps. We began banking in the cloud, tracking our finances in the cloud, and doing our taxes in the cloud. We stashed our photos, our documents, our data in the cloud.

Eventually, as the number of epic hacks increased, we started to lean on a curious psychological crutch: the notion of the “strong” password. It’s the compromise that growing web companies came up with to keep people signing up and entrusting data to their sites. It’s the Band-Aid that’s now being washed away in a river of blood.

Pages: 1 2 3 4 5 View All

Read More..